Lenalidomide
NDC 82293-010
Product Information
Lenalidomide is a ANDA-approved product labeled by Novugen Pharma (usa) Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a blue product. This product entry covers the primary NDC 82293-010 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
GREEN (C48329 - BLUE-GREEN OPAQUE CAP)
BLUE (C48333 - PALE BLUE OPAQUE BODY)
LEN;20MG Code Structure Chart
Product Details
What is NDC 82293-010?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LENALIDOMIDE (UNII: F0P408N6V4)
- LENALIDOMIDE (UNII: F0P408N6V4) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MANNITOL (UNII: 3OWL53L36A)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
- GELATIN (UNII: 2G86QN327L)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SHELLAC (UNII: 46N107B71O)
- AMMONIA (UNII: 5138Q19F1X)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1242231 - lenalidomide 2.5 MG Oral Capsule
- RxCUI: 1428947 - lenalidomide 20 MG Oral Capsule
- RxCUI: 602910 - lenalidomide 10 MG Oral Capsule
- RxCUI: 602912 - lenalidomide 5 MG Oral Capsule
- RxCUI: 643712 - lenalidomide 15 MG Oral Capsule
* Please review the full disclaimer at the bottom of this page.